Increased Serum Free Light Chains Precede the Presentation of Immunoglobulin Light Chain Amyloidosis

Elevated Subclinical Double-Stranded DNA Antibodies and Future Proliferative Lupus Nephritis

(2013) S. W. Olson et al.   Clinical Journal of the American Society of Nephrology

Relation between Asymptomatic Proteinase 3 Antibodies and Future Granulomatosis with Polyangiitis

(2013) S. W. Olson et al.   Clinical Journal of the American Society of Nephrology

Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

(2012) Shaji Kumar et al.   JOURNAL OF CLINICAL ONCOLOGY

Matched case-control studies: a review of reported statistical methodology

(2012) Daniel Niven et al.   Clinical Epidemiology

Evidence for a Functional Role of the Molecular Chaperone Clusterin in Amyloidotic Cardiomyopathy

(2011) Michael J. Greene et al.   AMERICAN JOURNAL OF PATHOLOGY

Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis

(2011) Giovanni Palladini et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis

(2011) B. Paiva et al.   BLOOD

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies

(2011) N. Korde et al.   BLOOD

The repertoire of   light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44

(2011) V. Perfetti et al.   BLOOD

Asymptomatic Autoantibodies Associate with Future Anti-glomerular Basement Membrane Disease

(2011) S. W. Olson et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis

(2010) Shaji K. Kumar et al.   AMERICAN JOURNAL OF HEMATOLOGY

Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study

(2010) Angela Dispenzieri et al.   LANCET

Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score

(2010) Shaji K. Kumar et al.   MAYO CLINIC PROCEEDINGS

A monoclonal gammopathy precedes multiple myeloma in most patients

(2009) B. M. Weiss et al.   BLOOD

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

(2009) O. Landgren et al.   BLOOD

How I treat amyloidosis

(2009) R. L. Comenzo   BLOOD

Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability

(2008) T. Bochtler et al.   BLOOD

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

(2008) A Dispenzieri et al.   LEUKEMIA

Pathogenesis and progression of monoclonal gammopathy of undetermined significance

(2008) J Bladé et al.   LEUKEMIA